Cargando…

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

Diabetics have higher morbidity and mortality in cardiovascular disease (CVD). A variety of antidiabetic agents are available for clinical choice. Cardiovascular (CV) safety assessment of these agents is crucial in addition to hypoglycemic effect before clinical prescription. Adenosine 5′-monophosph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Qingguo, Li, Xuan, Liu, Jia, Sun, Xiaodong, Rousselle, Thomas, Ren, Di, Tong, Nanwei, Li, Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379227/ https://www.ncbi.nlm.nih.gov/pubmed/30710062 http://dx.doi.org/10.1042/BSR20181995

Ejemplares similares

AMPK: a balancer of the renin–angiotensin system
por: Liu, Jia, et al.
Publicado: (2019)

AMPK: a therapeutic target of heart failure—not only metabolism regulation
por: Li, Xuan, et al.
Publicado: (2019)

Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
por: Kanemoto, Naohide, et al.
Publicado: (2019)

Not the final diagnosis: from Addison’s disease to POEMS syndrome: a case report and literature review
por: Xie, Xiaoxi, et al.
Publicado: (2021)

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations
por: Hirshberg, Boaz, et al.
Publicado: (2013)

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
por: Lee, Han Ah, et al.
Publicado: (2022)

Impact of oral antidiabetic agents on bone metabolism
por: Paul, Thomas V., et al.
Publicado: (2015)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
por: Schubert, Mario, et al.
Publicado: (2020)

The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials
por: Liu, Yuqi, et al.
Publicado: (2020)

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
por: Hermansen, Kjeld, et al.
Publicado: (2008)

Honey - A Novel Antidiabetic Agent
por: Erejuwa, Omotayo O., et al.
Publicado: (2012)

The effects of antidiabetic agents on heart failure
por: Wijnen, M., et al.
Publicado: (2021)

Anacardium occidentale Bark as an Antidiabetic Agent
por: Encarnação, Sofia, et al.
Publicado: (2022)

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials
por: Zhang, Fang, et al.
Publicado: (2017)

Modified High-Sucrose Diet-Induced Abdominally Obese and Normal-Weight Rats Developed High Plasma Free Fatty Acid and Insulin Resistance
por: Cao, Li, et al.
Publicado: (2012)

Ameliorative Effect of Berberine on Neonatally Induced Type 2 Diabetic Neuropathy via Modulation of BDNF, IGF-1, PPAR-γ, and AMPK Expressions
por: Zhou, Guangju, et al.
Publicado: (2019)

AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease
por: Goodman, Mark, et al.
Publicado: (2014)

GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway
por: Mazzieri, Alessio, et al.
Publicado: (2023)

Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets
por: Piccirillo, Francesco, et al.
Publicado: (2023)

Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events
por: Wu, Yuchao, et al.
Publicado: (2018)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Efficacy and Cardiovascular Safety of Antidiabetic Medications
por: Pappachan, Joseph M.
Publicado: (2021)

Corrigendum to “The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials” by Yuqi Liu,Juan Li, Jinfang Ma, Nanwei Tong
por: Liu, Yuqi, et al.
Publicado: (2020)

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

Letter Regarding “Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR”
por: Zhao, Li-Min, et al.
Publicado: (2021)

Exenatide: A New Promising Antidiabetic Agent
por: Chakraborti, C. K.
Publicado: (2010)

Role of red grape polyphenols as antidiabetic agents
por: Pandey, Kanti Bhooshan, et al.
Publicado: (2014)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
por: Ahn, Chang Ho, et al.
Publicado: (2019)

In the Search of Glycoside-Based Molecules as Antidiabetic Agents
por: Pałasz, Aleksandra, et al.
Publicado: (2019)

The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Antidiabetic Effect of Artemether in Db/Db Mice Involves Regulation of AMPK and PI3K/Akt Pathways
por: Bai, Xiaolin, et al.
Publicado: (2020)

Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
por: Arshad, Adam, et al.
Publicado: (2021)

Spatholobus suberectus Exhibits Antidiabetic Activity In Vitro and In Vivo through Activation of AKT-AMPK Pathway
por: Zhao, Peijun, et al.
Publicado: (2017)

AMPK, Mitochondrial Function, and Cardiovascular Disease
por: Wu, Shengnan, et al.
Publicado: (2020)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
por: Wang, Shu-Yi, et al.
Publicado: (2020)

The association of hypernatremia and hypertonic saline irrigation in hepatic hydatid cysts: A case report and retrospective study
por: Zeng, Rujun, et al.
Publicado: (2017)

Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Kan, Chengxia, et al.
Publicado: (2021)

Mechanochemical Synthesis of Thiazolidinone-Triazoles Derivatives as Antidiabetic Agents: Pharmacokinetics, Molecular Docking, and In Vitro Antidiabetic Properties
por: Taj, M. B., et al.
Publicado: (2023)

Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents
por: Almugadam, Babiker Saad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_48qgfu7ukumln3mtnlvrs2u2fm